Evan Schaffer is assistant professor of neuroscience at the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai. His lab uses mathematical tools to understand distributed computations in the brain, identify how these computations change with learning and identify how feedback from the body impacts cognition. Schaffer received his Ph.D. at the Center for Theoretical Neuroscience, in Larry Abbott’s lab at Columbia University. He completed his postdoctoral work in Richard Axel’s Lab at Columbia University
Evan Schaffer
Assistant professor of neuroscience
Icahn School of Medicine at Mount Sinai
Selected articles
- “Inhibitory stabilization of the cortical network underlies visual surround suppression” | Neuron
- “A complex-valued firing-rate model that approximates the dynamics of spiking networks” | PLoS Computational Biology
- “Odor perception on the two sides of the brain: Consistency despite randomness” | Neuron
- “The spatial and temporal structure of neural activity across the fly brain” | Nature Communications
- “Behavioral fingerprinting of the naked mole-rat uncovers signatures of eusociality and social touch” | bioRxiv
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read